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Fig. 1. The schematic diagram of the effects of inhibitors on protease
activation and cartilage degradation. Legend: The broad MMP inhibitor.
GM6001, almost completely inhibited the activation of Pro-ADAMTS-4.
Pro-MMP and cartilage breakdown. Surprisingly, tissue inhibitor of met-
alloproteinase (TIMP) -3 didn’t affect the activities of aggrecanases. But, it
blocked the activation of Pro-MMP-9, but not Pro-MMP-13, and inhibited
the release of MMP-derived aggrecan fragment. However, it induced an
increased release of CTX-II, the reason of which is unclear. Furin-like
proprotein convertase inhibitor (PCi) dramatically lowered the level of
active ADAMTS-4 and aggrecanase-mediated degradation, but oppositely
induced a huge release of active ADAMTS-5 to compensate the loss of
ADAMTS-4. PCi also increased the conversion of latent MMP-13 to active
form and the release of AGNxII. Blockade of cysteine proteases by E64
increased the level of active ADAMTS-4 and the release of type II collagen
fragment. Inhibition of serine proteases by Aprotinin prevented TNF-a and
OSM stimulated cartilage destruction through blocking the activation of
Pro-ADAMTS-4 and Pro-MMP13. Inhibition of aspartic protease by pep-
statin A had increased the level of active form of ADAMTS-4 and MMP-13
and the damage to type II collagen.
Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S172The level of O-GlcNAcylation, OGT and O-GlcNAcase expression was
assessed by western-blot employing speciﬁc antibodies.
Results: The amount of O-GlcNAcylated proteins was increased in
HOC 24 h after stimulation with different doses of IL-1a (1, 10 and
100 ng/ml), showing the highest accumulation with 10 ng/ml. This
concentration was chosen for stimulation of HOC during different
periods of time (3, 6, and 24 h). The increase in O-GlcNAc proteins
amount showed a peak of induction at 6 h. This accumulation occurs
especially in proteins between 50 to 150 KDa therefore showing a
similar O-GlcNAcylated proteins pattern to that observed in OA
cartilage. We also observed an increased expression of the three OGT
isoforms, nucleo-cytoplasmic (ncOGT), mitochondrial (mOGT) and
small (sOGT) in HOC as early as 3 h, although the peak of induction
was at 6 h. Three isoforms were increased in a similar grade,
without prevalence of sOGT as found in OA cartilage. IL-1a also
increased the presence of both OGA isoforms, long (OGA-L) and
short (OGA-S) after 3 and 6 h of stimuli. A clear prevalence of long
isoform was found along IL-1a stimulation whereas OGA-S had the
highest prevalence in OA cartilage.
Conclusions: To our knowledge, this is ﬁrst evidence of procatabolic
cytokines involvement in O-GlcNAc modiﬁcations. IL-1a can induce
accumulation of O-GlcNAc proteins in human OA chondrocytes.
Although both regulatory enzymes of this modiﬁcation, OGT and OGA,
are also increased with IL-1a stimulation, characteristic distribution of
the different isoforms in OA cartilage was not reached. IL-1a is in part
responsible of a dysregulation in the O-GlcNAc proteins modiﬁcation
during OA although other processes must be involved.
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Purpose: The speciﬁc protease degradation of aggrecan and type II
collagen in the cartilage matrix is a critical step in pathology of
osteoarthritis(OA). Several proteases are involved in the degradation
of the matrix proteins,amongst those are the important matrix
metalloproteinase (MMP)-9 , -13 and aggrecanase-1 and -2
(ADAMTS-4 and -5). The aim of the study was to gain better
understanding on the proteolytical proﬁle and sequence of events of
cartilage degradation by measuring the level of activated MMPs and
ADAMTS, as well as their speciﬁc degradation products of aggrecan
and type II collagen in the conditioned medium of a well described
cartilage explants model. Furthermore, the changes of proﬁle in
response to various types of broad spectrum protease inhibitors in
explants were monitored.
Methods: Bovine full-depth cartilage explants stimulated withTumor
Necrosis Factor alpha (TNF-a) and Oncostatin M (OSM) were cultured
for 21days with or without a number of inhibitors targeting different
types of proteases. Monoclonal antibodies were raised against the
active sites of ADAMTS-4, -5, MMP-9 and -13, and 4 ELISAs were
developed and technically validated. These, as well as AGNx1 (frag-
ments of ADAMTS degraded aggrecan), AGNxII (fragments of MMP
degraded aggrecan), and CTX-II (MMP-derived type II collagen frag-
ments) were quantiﬁed in the conditioned medium of the explants
cultures.
Results: In summary, we found that i) no proteolytical activity was
induced by medium alone; ii) the release of active ADAMTS-4 started at
day 14 and peaked at day 21, whereas no active ADAMTS-5 was
measured in the supernatant throughout stimulation of TNF-a and
OSM. Both active MMP-9 and -13 were released from day 17 and peaked
at day 21; iii) ADAMTS-mediated aggrecan degradation fragment
release peaked at day 10, returning to background level at day 19. In
contrast, the MMP fragments AGNxII and CTX-II peaked at the late stage
of stimulation; iv) The different effects of various inhibitors on the level
of aggrecanases, MMPs and cartilage breakdown have been observed
(illustrated in Fig.1).
Conclusions: The activation of proteases is a key point in cartilage
degradation, which is regulated in a complicated and integratedcascade process. The compensatory mechanisms could be triggered
following the blockade of one enzyme. This study suggests that this
model and measurement of biomarkers can be a useful tool to clarify
the mechanism of action of compounds and speed up the process of
selective protease inhibitor discovery.290
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Purpose: Chondrocytes possess a complex complement of membrane
ion channels, transporters and receptors, which have been shown to
have a range of functions within these cells; including maintenance of
membrane potential and cell volume regulation. Various transcript
studies have identiﬁed changes in ion channel gene expression with
osteoarthritis (OA), including aquaporin channels and calcium-selective
TRP channels. In vitro studies have shown that pro-inﬂammatory
cytokines can induce signiﬁcant chondrocyte apoptosis, one of the
hallmarks of OA. The aim of this study was to examine the function of
aquaporins and calcium-selective ion channels in healthy and cytokine-
stimulated cells.
Methods: Healthy cartilage was obtained from the stiﬂe and elbow
joints of young, skeletally mature bull terrier type dogs, euthanized for
unrelated veterinary reasons (aged2-3years; weight 12-15kg). Chon-
drocytes were isolated overnight at 37C using a 0.1% collagenase II
solution. The cell suspension was ﬁltered and washed before being
seeded into culture ﬂasks and cultured until conﬂuence was reached
(37C, 21% O2). Once cultures were established cells were split into two
groups: healthy control (standard DMEM supplemented with 2% pen-
icillin-streptomycin, 1% fungizone and 10% foetal calf serum) or
stimulated cells (DMEM as above plus TNFa and IL-1b both at 10ng/ml).
Chondroyctes were cytokine-stimulated for up to one week. Cells were
